Cardiac hypertrophy: A matter of translation

R. D. Hannan, A. Jenkins, A. K. Jenkins, Yves Brandenburger*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

130 Citations (Scopus)

Abstract

1. Left ventricular hypertrophy (LVH) of the heart is an adaptive response to sustained increases in blood pressure and hormone imbalances. Left ventricular hypertrophy is associated with programmed responses at the molecular and biochemical level in different subsets of cardiac cells, including the cardiac muscle cells (cardiomyocytes), fibroblasts, conductive tissue and coronary vasculature. 2. Regardless of the initiating cause, the actual increase in chamber enlargement is, in each case, due to an increase in size of a pre-existing cardiomyocyte population, with little or no change in their number; a process referred to as cellular hypertrophy. 3. An accelerated rate of global protein synthesis is the primary mechanism by which protein accumulation increases during cardiomyocyte hypertrophy. In turn, increased rates of synthesis are a result of increased translational rates of existing ribosomes (translational efficiency) and/or synthesis and recruitment of additional ribosomes (translational capacity). 4. The present review examines the relative importance of translational capacity and translational efficiency in the response of myocytes to acute and chronic demands for increased protein synthesis and the role of these mechanisms in the development of LVH.

Original languageEnglish
Pages (from-to)517-527
Number of pages11
JournalClinical and Experimental Pharmacology and Physiology
Volume30
Issue number8
DOIs
Publication statusPublished - 1 Aug 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cardiac hypertrophy: A matter of translation'. Together they form a unique fingerprint.

Cite this